| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING | 450 | 112 | 113 | 225 |
| Person Name | Explanation |
|---|---|
| ANTHONY T FISCHER |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL | 2010-05 | PURCHASE | 2011-04 | 2,475 | 3,005 | -530 | ||||
| INTEL CORP | 2010-05 | PURCHASE | 2011-04 | 934 | 1,171 | -237 | ||||
| FRONTIER COMMUNICATION | 1991-03 | PURCHASE | 2011-04 | 226 | 219 | 7 | ||||
| JOHNSON & JOHNSON | 1996-01 | PURCHASE | 2011-04 | 2,925 | 1,120 | 1,805 | ||||
| MERCK & CO | 1992-02 | PURCHASE | 2011-04 | 774 | 612 | 162 | ||||
| VERIZON COMMUNICATIONS | 1991-03 | PURCHASE | 2011-04 | 1,828 | 1,082 | 746 | ||||
| GNMA II - 3069 | 2009-01 | PURCHASE | 2011-12 | 51 | 51 | |||||
| GNMA 139793 | 2009-01 | PURCHASE | 2011-12 | 9 | 9 | |||||
| GNMA - 149320 | 2009-01 | PURCHASE | 2011-12 | 67 | 67 | |||||
| GNMA - 220668 | 2011-01 | PURCHASE | 2011-12 | 59 | 59 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| EXXON | FMV | 8,476 | 8,476 |
| JOHNSON & JOHNSON | AT COST | 2,240 | 6,558 |
| VERIZON | AT COST | 2,163 | 4,012 |
| GNMA SF 003069M | AT COST | 425 | 425 |
| GNMA 139793 | AT COST | 50 | 50 |
| GNMA 149320X | AT COST | 375 | 375 |
| GNMA 220668X | AT COST | 219 | 220 |
| TEVA PHARMACEUTICAL | AT COST | ||
| FRONTIER COMMUNICATIONS | AT COST | ||
| INTEL CORP | AT COST |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| 100 | 100 |
| Description | Beginning of Year - Book Value | End of Year - Book Value |
|---|---|---|
| INVESTMENT MARGIN AC BAL | 8,913 | 1,502 |